SCHEMBL30936620

SCHEMBL30936620

CN(C(=O)OC(C)(C)C)c1c(Cl)cccc1[N+](=O)[O-]

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.44
LMNA P02545 3/20 0.44
NPSR1 Q6W5P4 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
POLB P06746 1/20 0.40
MAPT P10636 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
HPGD P15428 1/20 0.38
CYP2C19 P33261 3/20 0.38
NPC1 O15118 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HTT P42858 1/20 0.37
CRHR1 P34998 1/20 0.37
CYP1A2 P05177 2/20 0.36
CYP2C9 P11712 2/20 0.36
BRD4 O60885 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30287226 0.88 ALDH1A1 (0.45) ALDH1A1LMNANPSR1L3MBTL1POLB
SCHEMBL31720604 0.85 TDP1 (0.46) ALDH1A1LMNANPSR1L3MBTL1MAPT
SCHEMBL26091291 0.85 ALDH1A1 (0.43) ALDH1A1LMNANPSR1L3MBTL1POLB
SCHEMBL23540991 0.84 NPSR1 (0.38) ALDH1A1LMNANPSR1L3MBTL1MAPT
SCHEMBL30936632 0.84 NPSR1 (0.38) ALDH1A1LMNANPSR1L3MBTL1MEN1
SCHEMBL30893303 0.84 NPSR1 (0.38) ALDH1A1LMNANPSR1L3MBTL1MAPT
SCHEMBL7476967 0.83 TSHR (0.50) ALDH1A1NPSR1L3MBTL1POLBMAPT
SCHEMBL25174512 0.80 KMT2A (0.34) ALDH1A1LMNANPSR1MAPTMEN1
SCHEMBL25171636 0.80 LMNA (0.33) ALDH1A1LMNANPSR1POLBMAPT
SCHEMBL31220170 0.80 LMNA (0.33) ALDH1A1LMNANPSR1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250340510-A1 Substituted Phenylbenzenesulfonamide Derivatives and Uses Thereof NINE SQUARE THERAPEUTICS CORPORATION (US) 2025-11-06 US disclosed
EP-4608389-A2 SUBSTITUTED PHENYLBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF Nine Square Therapeutics Corporation (US) 2025-09-03 EP disclosed
WO-2024092235-A2 SUBSTITUTED PHENYLBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF NINE SQUARE THERAPEUTICS CORPORATION (US) 2024-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250340510-A1 Substituted Phenylbenzenesulfonamide Derivatives and Uses Thereof TRPM2, TRPM6, TRPM5 ALDH1A1 3137/4885LMNA 1726/4885NPSR1 680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.